ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

SILWANA SIDORCZUK MD

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,489Medicare Part D Prescriptions Filled, Including Refills

Rank: 59 out of 546

$515K Total Retail Price of All Prescriptions

Rank: 51 out of 546

443 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maine
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 443 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

3% of this provider’s 443 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 5,644 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $65 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maine
LISINOPRIL 301 216 1 1
WARFARIN SODIUM 265 254 2 13
SIMVASTATIN 260 197 3 2
FUROSEMIDE 233 204 4 5
LEVOTHYROXINE SODIUM 230 198 5 3
METOPROLOL TARTRATE 218 156 6 6
CITALOPRAM HBR 203 178 7 21
PANTOPRAZOLE SODIUM 180 140 8 18
OMEPRAZOLE 151 104 9 4
ATORVASTATIN CALCIUM 136 88 10 11
ATENOLOL 129 115 11 12
METFORMIN HCL 123 72 12 10
ADVAIR DISKUS 118 88 13 20
HYDROCHLOROTHIAZIDE 113 63 14 7
POLYETHYLENE GLYCOL 3350 103 76 15 68
AMITRIPTYLINE HCL 97 56 R 16 48
AMLODIPINE BESYLATE 94 71 17 9
METOPROLOL SUCCINATE 94 59 17 17
LIDODERM 81 67 19 73
GABAPENTIN 79 62 20 16
LOVASTATIN 71 63 21 22
NEXIUM 70 37 22 52
SERTRALINE HCL 69 53 23 14
CYCLOBENZAPRINE HCL 65 28 R 24 34
SPIRIVA 64 40 25 28
LOSARTAN POTASSIUM 62 56 26 24
LANTUS SOLOSTAR 62 51 26 159
PREDNISONE 61 53 28 29
ZOLPIDEM TARTRATE 59 52 29 26
MELOXICAM 58 27 30 58
PROAIR HFA 55 23 31 27
SULFAMETHOXAZOLE-TRIMETHOPRIM 54 46 32 104
FLUTICASONE PROPIONATE 54 30 32 42
TRAMADOL HCL 54 23 32 19
PAROXETINE HCL 54 37 32 43
KLOR-CON M20 52 31 36 57
QUETIAPINE FUMARATE 52 33 36 72
POTASSIUM CHLORIDE 50 37 38 30
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 19, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.